000 | 01027 a2200289 4500 | ||
---|---|---|---|
005 | 20250512233945.0 | ||
264 | 0 | _c19830311 | |
008 | 198303s 0 0 eng d | ||
022 | _a0028-4793 | ||
024 | 7 |
_a10.1056/NEJM198302103080604 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKyle, R A | |
245 | 0 | 0 |
_aLong-term survival in multiple myeloma. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cFeb 1983 |
||
300 |
_a314-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAlkylating Agents _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelphalan _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
773 | 0 |
_tThe New England journal of medicine _gvol. 308 _gno. 6 _gp. 314-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM198302103080604 _zAvailable from publisher's website |
999 |
_c6822967 _d6822967 |